CDC42SE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.339400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.213800E-01
Normal-vs-Stage2
5.602400E-01
Normal-vs-Stage3
2.587000E-01
Normal-vs-Stage4
8.008000E-01
Stage1-vs-Stage2
3.236400E-01
Stage1-vs-Stage3
7.079800E-01
Stage1-vs-Stage4
1.614840E-01
Stage2-vs-Stage3
2.507600E-01
Stage2-vs-Stage4
3.137000E-01
Stage3-vs-Stage4
1.908390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.284000E-01
Normal-vs-AfricanAmerican
5.948400E-01
Normal-vs-Asian
2.686600E-01
Caucasian-vs-AfricanAmerican
7.334400E-01
Caucasian-vs-Asian
7.241400E-01
AfricanAmerican-vs-Asian
6.412400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.938230E-01
Normal-vs-Female
5.133000E-01
Male-vs-Female
4.981200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.558200E-01
Normal-vs-Age(41-60Yrs)
6.620400E-01
Normal-vs-Age(61-80Yrs)
4.897800E-01
Normal-vs-Age(81-100Yrs)
4.675200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.183600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.456000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.548400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.646300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.445600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.068000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.746200E-01
Normal-vs-Daily Drinker
1.494160E-01
Normal-vs-Weekly Drinker
3.143600E-01
Normal-vs-Occasional Drinker
6.031200E-01
Normal-vs-Social Drinker
1.924440E-01
Non Drinker-vs-Daily Drinker
8.479200E-01
Non Drinker-vs-Weekly Drinker
4.527200E-01
Non Drinker-vs-Occasional Drinker
6.424500E-02
Non Drinker-vs-Social Drinker
8.540000E-01
Daily Drinker-vs-Weekly Drinker
4.352400E-01
Daily Drinker-vs-Occasional Drinker
8.586000E-02
Daily Drinker-vs-Social Drinker
7.570400E-01
Weekly Drinker-vs-Occasional Drinker
3.890800E-01
Weekly Drinker-vs-Social Drinker
6.314800E-01
Occasional Drinker-vs-Social Drinker
1.786630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.485600E-01
Normal-vs-Grade 2
5.445900E-02
Normal-vs-Grade 3
5.128300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.164500E-03
Grade 1-vs-Grade 3
3.115100E-03
Grade 1-vs-Grade 4
4.485600E-01
Grade 2-vs-Grade 3
5.975800E-01
Grade 2-vs-Grade 4
5.445900E-02
Grade 3-vs-Grade 4
5.128300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.936820E-01
Normal-vs-NonDiabetic
5.277000E-01
Diabetic-vs-NonDiabetic
9.123200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.113000E-01
Normal-vs-NoPancreatitis
5.288200E-01
Pancreatitis-vs-NoPancreatitis
5.499800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.680800E-01
Normal-vs-N1
5.283400E-01
N0-vs-N1
5.661200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.209400E-01
Normal-vs-TP53-NonMutant
1.456410E-01
TP53-Mutant-vs-TP53-NonMutant
3.580000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
